DOWN
ABOUT
INCE Capital is a global venture capital firm with an investment focus on early to expansion-stage companies that spearhead innovation in AI, technology, consumer, and biotech industries.
learn more
TEAM
NEWS
11.27
2025
INCE Capital Portfolio Company WEFLY Signs 105 eVTOL Purchase Agreements With Three Enterprises
11.25
2025
INCE Capital’s Portfolio Company Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs
10.23
2025
INCE Capital’s Portfolio Company LiblibAI Annouces $130 Million Series B Financing
09.24
2025
INCE Capital's Portfolio Company Avenzo Therapeutics Announces $60 Million Series B Financing